PRPO实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (1 May 2024 @ 00:59):

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services...

Stats
今日成交量	3 345.00
平均成交量	5 280.00
市值	7.93M
EPS	$0 ( 2024-04-04 )
下一个收益日期	( $-0.930 ) 2024-05-15
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.280
ATR14	$0.118 (2.04%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	Laporte Kathleen	Buy	9 693	Common Stock
2024-04-15	Sandberg Richard A	Buy	5 913	Common Stock
2024-04-15	Cossman Jeffrey	Buy	8 143	Common Stock
2024-04-15	Cohen David Seth	Buy	3 575	Common Stock
2024-04-15	Andrews Ronald Asbury	Buy	3 153	Common Stock

INSIDER POWER
99.41
Last 96 transactions
Buy: 2 731 117 \| Sell: 221 280

Precipio Inc 相关性

10 最正相关
SLGC	0.874
VUZI	0.835
SIFY	0.833
MOGO	0.829
TCON	0.821
SBGI	0.811
ISPC	0.807
STAA	0.802
PCT	0.801

10 最负相关
BNIXU	-0.894

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Precipio Inc 财务报表

Annual	2023
营收:	$15.20M
毛利润:	$4.50M (29.62 %)
EPS:	$-4.51

FY	2023
营收:	$15.20M
毛利润:	$4.50M (29.62 %)
EPS:	$-4.51

FY	2022
营收:	$9.41M
毛利润:	$2.51M (26.67 %)
EPS:	$-10.73

FY	2021
营收:	$8.85M
毛利润:	$2.39M (27.03 %)
EPS:	$-0.400

Financial Reports:

No articles found.

Precipio Inc

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.